RecruitingNot Applicable

Whole Body MRI for Non-invasive Lesion Detection and Therapy Follow-up: Study With Patients With Radiographic axSpA and Non-radiographic axSpA

China100 participantsStarted 2022-01-01

Plain-language summary

This study aims to further improve and expand the WB-MRI imaging evaluation cohort of axSpA patients to complete dynamic follow-up and condition assessment. Based on the WB-MRI features, the association of WB-MRI signs with disease activity, inflammation, and structural damage will be analyzed. At the same time, in-depth data mining was conducted and machine learning was used to construct a new axSpA disease activity assessment model based on WB-MRI data, and the accuracy and reliability of the model were clearly evaluated in the discovery cohort and validation cohort.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: Include newly referred patients if: The onset of symptoms (back pain/arthritis/enthesitis) \< 45 years Undiagnosed disease with the following symptoms: chronic back pain (duration of back pain more than 3 months) and/or peripheral arthritis (asymmetric arthritis/predominantly of the lower limbs) and/or enthesitis and/or dactylitis Exclusion Criteria: And diagnosed with non-radiographic or radiographic axial SpA

What they're measuring

WB-MRI imaging characteristics of patients with axSpA.

Timeframe: Two years

Trial details

NCT IDNCT07230327

SponsorThe First Affiliated Hospital with Nanjing Medical University

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2026-01

Contact for this trial

Wenfeng Tan, Dr

+8618061202878 tw2006@njmu.edu.cn

View on ClinicalTrials.gov More Spondyloarthritis (SpA) trials